Inhibition Of IGF1R by IGF-1R/IR Inhibitor OSI906 as a Targeted Therapy for Glioblastoma: In Vitro & in Vivo Studies

被引：0
|
作者：
Fernandez, M. C. [1 ]
Martin, A. [1 ]
Clement, F. [1 ]
Venara, M. C. [1 ]
Garcia Lombardi, M. [2 ]
Bergada, I [1 ]
Gutierrez, M. [1 ]
Pennisi, P. A. [1 ]
机构：
[1] Hosp Ninos Dr R Gutierrez, CONICET, Ctr Invest Endocrinol Dr Cesar Bergada, CEDIE,FEI,Div Endocrinol, Buenos Aires, DF, Argentina
[2] Hosp Ninos Dr R Gutierrez, Serv Oncol, Buenos Aires, DF, Argentina
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2019年 / 92卷
关键词：
IGF1R; Pediatric glioma; OSI906;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP5
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β
    Bielen, Aleksandra
    Perryman, Lara
    Box, Gary M.
    Valenti, Melanie
    Brandon, Alexis de Haven
    Martins, Vanessa
    Jury, Alexa
    Popov, Sergey
    Gowan, Sharon
    Jeay, Sebastien
    Raynaud, Florence I.
    Hofmann, Francesco
    Hargrave, Darren
    Eccles, Suzanne A.
    Jones, Chris
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1407 - 1418
  • [32] ENHANCED EFFICACY OF IGF1R INHIBITION IN PEDIATRIC GLIOBLASTOMA BY COMBINATORIAL TARGETING OF PDGFRα/β
    Bielen, Aleksandra
    Bjerke, Lynn
    Box, Gary
    Valenti, Melanie
    Brandon, Alexis de Haven
    Martins, Vanessa
    Jury, Alexa
    Popov, Sergey
    Gowan, Sharon
    Jeay, Sebastien
    Raynaud, Florence
    Hofmann, Francesco
    Hargrave, Darren
    Eccles, Suzanne
    Jones, Chris
    NEURO-ONCOLOGY, 2011, 13 : I16 - I17
  • [33] HER receptor signaling confers resistance to IGF-1R targeted therapy
    Haluska, P.
    Carboni, J. M.
    Yu, C.
    Ten Eyck, C.
    Attar, R. M.
    Asmann, Y. W.
    Sagar, M.
    Wong, T. W.
    Gottardis, M. M.
    Erlichman, C. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] IGF 1R Overexpression and Nuclear Localization in Glioblastoma Cells: In Vitro & In Vivo Studies
    Martin, Ayelen
    Pennisi, P.
    Gutierrez, M.
    Bergada
    Venara, M.
    Clemet, F.
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 3 - 3
  • [35] Human Kinase IGF1R/IR Inhibitor Linsitinib Controls the In Vitro and Intracellular Growth of Mycobacterium tuberculosis
    Wang, Heng
    Bi, Jing
    Zhang, Yuan
    Pan, Miaomiao
    Guo, Qinglong
    Xiao, Genhui
    Cui, Yumeng
    Hu, Song
    Chan, Chi Kin
    Yuan, Ying
    Kaneko, Takushi
    Zhang, Guoliang
    Chen, Shawn
    ACS INFECTIOUS DISEASES, 2022, 8 (10): : 2019 - 2027
  • [36] Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators
    Turvey, Samuel J.
    McPhillie, Martin J.
    Kearney, Mark T.
    Muench, Stephen P.
    Simmons, Katie J.
    Fishwick, Colin W. G.
    RSC MEDICINAL CHEMISTRY, 2022, 13 (04): : 360 - 374
  • [37] KW-2450, a novel orally-active dual IGF1R/IR inhibitor: Antitumor effects in vitro and in vivo
    Maekawa, Yoshimi
    Koizumi, Fumito
    Kashima, Naomi
    Suzuki, Masayo
    Umehara, Hiroshi
    Takahashi, Hiroko
    Nakamura, Hiroaki
    Nara, Shinji
    Nakazato, Tomoyuki
    Kanda, Yutaka
    Takahashi, Takeshi
    Akinaga, Shiro
    Shiotsu, Yukimasa
    Soga, Shiro
    CANCER RESEARCH, 2011, 71
  • [38] Can we unlock the potential of IGF-1R inhibition in cancer therapy?
    King, Helen
    Aleksic, Tamara
    Haluska, Paul
    Macaulay, Valentine M.
    CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1096 - 1105
  • [39] Discovery of a potent small molecule inhibitor of IGF-1R
    Frennesson, David
    Wittman, Mark
    Saulnier, Mark
    Carboni, Joan
    Attar, Ricardo
    Balimane, Praveen
    Chang, Chiehying
    Chen, Cliff
    Discenza, Lorell
    Gottardis, Marco
    Greer, Ann
    Hurlburt, Warren
    Johnson, Walter
    Langley, David
    Lee, Francis
    Li, Aixin
    Liu, Peiying
    Mastalerz, Harold
    Mathur, Arvind
    Menard, Krista
    Patel, Karishma
    Sack, John
    Sang, Xiaopeng
    Traeger, Sarah
    Trainor, George
    Velaparthi, Upender
    Yang, Zheng
    Zhang, Guifen
    Zimmermann, Kurt
    Vyas, Dolatrai
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [40] OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway
    Liu, Li
    Liang, Changyan
    Zhuo, Chenya
    Jiang, Huiyun
    Ye, Huixia
    Ruan, Tianyuan
    Song, Jiao
    Jiang, Senwei
    Zhang, Yu
    Li, Xiaomao
    MEDICAL ONCOLOGY, 2022, 39 (02)
12345